 MIAMI, Sept. 08, 2022 GLOBE NEWSWIRE -- Fortress Biotech, Inc. NASDAQ: FBIO Fortress or the Company, an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing or monetizing promising therapeutic products and product candidates, today announced that Lindsay A. Rosenwald, M.D., Chairman and Chief Executive Officer, will present a corporate update virtually at the H.C. Wainwright 24th Annual Global Investment Conference and the Company will participate in one-on-one meetings on Tuesday, September 13, 2022. 